News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
335 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Biotech Beach
Tandem Diabetes Care to Present at the Deutsche Bank 43rd Annual Health Care Conference
Tandem Diabetes Care®, Inc. announced that Kim Blickenstaff, president and CEO, will present a company update at the Deutsche Bank 43rd Annual Health Care Conference in Boston, MA.
May 1, 2018
·
1 min read
Business
Intersect ENT Reports First Quarter 2018 Results
Intersect ENT, Inc. reported financial results for the first quarter ended March 31, 2018.
May 1, 2018
·
6 min read
Genetown
Alnylam to Webcast Presentations at Several Upcoming May Investor Conferences
Alnylam Pharmaceuticals, Inc. announced that management will present company overviews at the following conferences:
May 1, 2018
·
1 min read
BioMidwest
IMRIS and Hill-Rom Announce Commercial Launch of New Magnetic Resonance Neurosurgical Table
IMRIS and Hill-Rom (NYSE: HRC) have commercially launched a new multi-functional operating room (OR) table specifically designed for the IMRIS Surgical Theatre.
May 1, 2018
·
4 min read
Business
Zymeworks Reports 2018 First Quarter Financial Results
Zymeworks Inc. reported financial results for the quarter ended March 31, 2018.
May 1, 2018
·
7 min read
Business
Aurinia Pharmaceuticals to Release First Quarter 2018 Financial Results on May 10, 2018
Aurinia Pharmaceuticals Inc. announced that it will release its first quarter 2018 financial results on Thursday, May 10, 2018, after the market closes.
May 1, 2018
·
1 min read
Business
Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2018 Financial Results on May 10, 2018
Eagle Pharmaceuticals, Inc. announced that the Company will release its 2018 first quarter financial results on Thursday, May 10, 2018, before the market opens.
May 1, 2018
·
1 min read
Biotech Beach
Masimo to Present at Deutsche Bank 43rd Annual Health Care Conference
Masimo announced that its management is scheduled to present at the Deutsche Bank 43rd Annual Health Care Conference at the Intercontinental Hotel in Boston on Tuesday, May 8, 2018 at 9:20 a.m. Eastern Time.
May 1, 2018
·
2 min read
FDA
Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma
Novartis announced the US Food and Drug Administration (FDA) has approved Kymriah® (tisagenlecleucel) suspension for intravenous infusion for its second indication.
May 1, 2018
·
17 min read
Policy
Notice to the media - Technical Briefing to provide an update on the Government of Canada’s latest actions in response to the opioid crisis
Health Canada will publish final regulations in Canada Gazette
May 1, 2018
·
1 min read
Previous
6 of 34
Next